The AHA’s PREVENT equations are the modern, race-free risk tools that estimate 10- and 30-year total CVD risk—including heart failure. Early data show PREVENT often labels fewer people “high risk” than older PCE scores. Book a PREVENT-based review and leave with a clear, doable plan.

GLP-1 medicines now go beyond weight loss: semaglutide cut major cardiovascular events by ~20% in people with overweight/obesity and established CVD—even without diabetes. Learn who benefits, side effects, costs in Australia, and how lifestyle still matters. Same-day telehealth cardiometabolic consults available at Zelica.

Australia’s national Lung Cancer Screening Program is here. If you’re 50–70 with a 30 pack-year smoking history (current or quit ≤10 years), you may qualify for a free Medicare-funded low-dose CT every two years. We’ll assess your risk, enrol you with the NCSR, and organise the referral.